Chronic Kidney Disease Trial, Recruiting NCT06631820 Sponsor: Karolinska Institutet Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06631820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your kidneys are working at a low level (a kidney function score below 29 out of a possible 100+), as measured by a standard blood test
  • You do not have any known liver disease, whether long-term or recent
  • Your kidney specialist does not expect you to need dialysis or another kidney replacement treatment within the next 4 months

Who may not be able to join:

  • You currently show signs of an active infection
  • You have a condition called acute vasculitis (sudden inflammation of the blood vessels — confirm with trial site)
  • You have Type 1 diabetes
  • You are currently taking steroid medications
  • You have previously had an organ transplant
  • You have difficulty walking and use a wheelchair or are on bed rest
  • You are receiving end-of-life care
  • You have a serious, advanced neurological (brain or nervous system) condition
  • You have been diagnosed with a condition that affects memory or thinking ability
  • You currently have an active cancer diagnosis
  • You are already taking part in another clinical trial that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +460762931786

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 January 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Epicatechin supplementation effect on myosteatosis; Epicatechin supplementation effect on muscle function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov